Christoph U. Correll, MD

Dr Correll is professor at the Institute of Behavioral Science, Feinstein Institutes for Medical Research; medical director of the Recognition and Prevention Program in the Department of Psychiatry at Zucker Hillside Hospital; and professor of Psychiatry and Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.

Articles by Christoph U. Correll, MD

Paliperidone Palmitate for Schizophrenia: Research on New Innovative Treatment for Unmet Needs

ByChristoph U. Correll, MD

September 11th 2023

Christoph Correll, MD, shares more on paliperidone palmitate 6-month for the treatment of schizophrenia.

Adverse Effects of Antipsychotics and Mood Stabilizers

ByHarold E. Carlson, MD,Christoph U. Correll, MD

December 31st 2007

Although psychotropic medications have revolutionized the treatment of many psychiatric disorders, the benefits sometimes come at a price.

Christoph U. Correll, MD

Articles by Christoph U. Correll, MD

Paliperidone Palmitate for Schizophrenia: Research on New Innovative Treatment for Unmet Needs

Adverse Effects of Antipsychotics and Mood Stabilizers

Trending on Psychiatric Times

FDA Grants Clearance to Motivista, the First Authorized Treatment for Negative Symptoms of Schizophrenia

Muscarinic Treatment for Schizophrenia: A Presynaptic Answer to a Presynaptic Problem

Blood-Based Biomarkers for Alzheimer Disease: Accuracy, Limits, and Confounders

First Patient Dosed in Phase 2a Trial of GlyphAgo for Generalized Anxiety Disorder and Sleep Disturbance

How a Learning Health Network Could Transform Bipolar Disorder Treatment: A Conversation With Andrew Nierenberg, MD